Comparing early-onset (≤40 years of age) and control (> 40 years) CRC groups, no difference emerged in the occurrence of TB, as well as lymphatic invasion, mucinous histology, or tumor-infiltrating lymphocytes, neither in KRAS mutations occurrence. The gene discussed is KRAS; the disease is neoplasm.